Drug Discovery Enhanced by Artificial Intelligence

Woo Sung Son

doi:10.26717/BJSTR.2018.12.002189

Mini ReviewOpen Access

Drug Discovery Enhanced by Artificial Intelligence

Volume 12 - Issue 1

Woo Sung Son*

Author Information Open or Close
- College of Pharmacy and Institute of Pharmaceutical Sciences, CHA University, 120 Haeyong-ro, Pocheon-si, Gyeonggi-do, 11160, Republic of Korea

Received: October 08, 2018; Published: December 12, 2018

DOI: 10.26717/BJSTR.2018.12.002189

Full Text PDF

To view the Full Article Peer-reviewed Article PDF

Abstract

Artificial intelligence, one of the key technologies in the era of the 4th Industrial Revolution, is expected to greatly affect traditional drug discovery. Artificial intelligence is attracting attention as an innovative technology that can dramatically reduce the high cost and time required for the new drug discovery. At this stage, artificial intelligence is mainly used to search for candidate molecules during drug discovery, but it is highly likely to be actively used in drug discovery through open innovation in the future. In this paper, it is presented the current state of artificial intelligence in each stage of a new drug discovery and prospect for the future usability.

Keywords :Artificial Intelligence; Drug Discovery; Drug Targets; Drug Candidates; Clinical Trials; Post Monitoring

Abbreviations : AI: Artificial Intelligence; SBDD: Structure-Based Drug Discovery; NMR: Nuclear Magnetic Resonance Spectroscopy; CMC: Chemistry, Manufacturing, and Control; GMP: Good Manufacturing Practice; OCR: Optical Character Recognition

Introduction| Conclusion| Acknowledgement| References|